Marcella M. Bodner has nearly 20 years of experience formulating both offensive and defensive intellectual property strategies that create and maximize value through patent portfolio development, licensing, and enforcement. A critical component of such strategies is an emphasis on risk assessment and resource and budget management and allocation.
Ms. Bodner’s experience includes the patentability assessment of new inventions, patent landscape studies, the preparation and prosecution of patent applications in the United States and worldwide, appeal of rejections at the Patent and Trademark Appeals Board, defense of third party oppositions at the European Patent Office, and opinions regarding infringement and freedom-to-operate for products and processes.
For those engaged in joint ventures and other collaborations, Ms. Bodner negotiates and drafts contracts relating to the development, ownership, and transfer of patents. This includes research collaboration agreements, non-disclosure (secrecy) agreements, assignments, joint venture agreements, toll manufacturing agreements and technology licenses.
Ms. Bodner applies her patent prosecution and technical expertise on behalf of clients enforcing or defending against the enforcement of patents in United States federal courts and in post grant proceedings at the United States Patent and Trademark Office including inter partes reviews (IPRs), covered business method reviews (CBMs), post-grant reviews (PGRs) and ex parte reexaminations.
With a strong chemical engineering background, Ms. Bodner’s technical expertise includes chemical compositions and methods for making them, uses for chemical compositions including coatings, detergents, nutritional compositions, health and beauty products, pharmaceuticals, plastics, specialty monomers, marker/tracing compositions, and metal oxide catalysts. She also has substantial technical expertise with mechanical devices, their components and methods of operation, such as process equipment, safety equipment, biological modeling systems, medical devices, and surgical implants.
As published in: Bloomberg Law April 7, 2020
As published in: Bloomberg Law December 23, 2019
As published in: Bloomberg Law August 29, 2019
As published in: Bloomberg Law May 10, 2019
As published in: BioCentury May 9, 2019
Intellectual Property Law May 19, 2020Marcella M. Bodner
World Intellectual Property Review April 23, 2018Marcella M. Bodner
Law360 April 20, 2018Marcella M. Bodner
The materials on this site have been prepared by Cole Schotz P.C. for general informational purposes only and are not intended to constitute legal advice. Viewers should not act upon this information without seeking professional counsel on the specific facts and circumstances in question from an attorney licensed in their jurisdiction. Use of this site does not create an attorney-client relationship between the user and Cole Schotz or any lawyer(s) within the firm. Any information sent to Cole Schotz or its lawyers through this site will not be treated as confidential and is not protected by the attorney-client privilege.
© Cole Schotz P.C.
This website is an advertisement for a law firm. Statements and previous outcomes do not imply similar results in your matters.
© Cole Schotz P.C.
For Important Legal Updates and Resources on the Coronavirus Click Here.